Therapeutic fusion protein
- 专利权人:
- F. Hoffmann-La Roche AG
- 发明人:
- Bohrmann, Bernd,Freskgard, Per-Ola,Knoetgen, Hendrik,Niewoehner, Jens
- 申请号：
- AU2014298519
- 公开号：
- AU2014298519A1
- 申请日:
- 2014.07.30
- 申请国别(地区):
- AU
- 年份:
- 2016
- 代理人:
- 摘要：
- The invention relates to a fusion protein comprising an antibody directed to Aβ, a monovalent binding entity which binds to a blood brain barrier receptor and a neprilysin.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- COMBINATION OF TUMOR-ASSOCIATED SURFACE PROTEIN ANTIGENS AND TUMOR-ASSOCIATED SUGARS IN THE TREATMENT AND DIAGNOSIS OF CANCER
- 암 (골수종)을 치료하기 위한 항-CS1 항체와 항-PD1 항체의 조합
- HDAC INHIBITOR AND ANTIBODY AGAINST PD-L1 FOR TREATMENT OF OVARIAN CANCER
- ANTITUMOR COMBINATIONS CONTAINING ANTIBODIES RECOGNIZING SPECIFICALLY CD38 AND CYLOPHOSPHAMIDE
- ANTITUMOR COMBINATIONS CONTAINING ANTIBODIES RECOGNIZING SPECIFICALLY CD38 AND VINCRISTINE
